Dr Helen Young Dr Helen Young Senior Commercialisation Associate
Helen works across the Life Sciences Team, providing support for the evaluation, IP protection and licensing of technologies arising from the Schools of Biological Sciences and Clinical Medicine.

Recent support has been for the licensing of technologies to Phoremost, Storm Therapeutics and PredictImmune.

Prior to joining Cambridge Enterprise, Helen spent 15 years working for various SME’s in the biotech sector within the Cambridge region, where she held positions in process development and formulation for vaccines and biotherapeutics.

Helen has a PhD in Mucosal Glycobiology from the University of Manchester.

Helen joined Cambridge Enterprise in October 2013.